A Different Side of
VDyne Valve for the Treatment of Tricuspid Regurgitation
VDyne is a privately held medical device company located near Minneapolis, Minnesota, U.S.A.
VDyne is developing transcatheter valve technologies for the treatment of the debilitating and life-threatening effects of tricuspid regurgitation.
VDyne has developed a proprietary valve technology that is - quite literally - turning twenty years of transcatheter valve delivery "on its side". VDyne's unique side-delivery technology enables physicians to treat a broader patient population than is otherwise available with existing and developing technologies.
VDyne is presently undertaking early feasibility (clinical) studies in the United States, Europe and Australia.
VDyne is backed by two (2) of the world's largest medical device companies.
This website is intended for people seeking information about VDyne for investment and business purposes only. This website contains information about the VDyne Valve technology that is not available, or approved, in any country.
Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including the VDyne Valve technology. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.